Type I-Polarized Autologous Dendritic Cell Vaccine With Tumor Blood Vessel Antigen-Derived Peptides in Metastatic Breast Cancer Patients
Clinical trial NCT02479230 · COMPLETED
Trial details
- NCT number
- NCT02479230
- Sponsor
- Joseph Baar, MD, PhD
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-17
- Primary completion
- 2019-10-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.